During the past decade, Muhimbili National Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Muhimbili National Hospital" #1 sponsor was "Helse Stavanger HF" with 2 trials, followed by "King's College London" with 1 trials sponsored, "London School of Hygiene and Tropical Medicine" with 1 trials sponsored, "Massachusetts General Hospital" with 1 trials sponsored and "University of California, San Francisco" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Muhimbili National Hospital" #1 collaborator was "African Esophageal Cancer Consortium (AfrECC)" with 1 trials as a collaborator, "Arthur Davison Children's Hospital" with 1 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Haydom Lutheran Hospital" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Muhimbili National Hospital" are "Acute Stroke" (1 trials), "Birth Asphyxia" (1 trials), "Diabetes, Autoimmune" (1 trials), "Esophageal Cancer" (1 trials) and "Fetal Heart Rate Abnormalities" (1 trials). Many other conditions were trialed in "Muhimbili National Hospital" in a lesser frequency.

Most popular intervention types in "Muhimbili National Hospital" are "Other" (3 trials), "Device" (2 trials), "Drug" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Assessment of patient-reported outcomes (PROs)" (1 trials), "Doppler, Fetal heart rate" (1 trials), "Fetoscope, Fetal heart rate" (1 trials), "Fluoxetine 20 MG Oral Tablet" (1 trials) and "Hand-held Doppler" (1 trials). Other intervention names were less common.

The vast majority of trials in "Muhimbili National Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Muhimbili National Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Muhimbili National Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Muhimbili National Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".